Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02543879
Title Study of a Novel BET Inhibitor FT-1101 in Patients With Relapsed or Refractory Hematologic Malignancies
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Forma Therapeutics, Inc.
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Cedars Sinai Los Angeles California 90048 United States Details
Florida Cancer Specialists Sarasota Florida 34232 United States Details
Moffitt Cancer Center Tampa Florida 23985 United States Details
Northwestern University Chicago Illinois 60611 United States Details
University of Maryland, Greenebaum Comprehensive Cancer Center Baltimore Maryland 21201 United States Details
Levine Cancer Institute Charlotte North Carolina 28204 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from for the field